About Foresight Diagnostics
Foresight Diagnostics is a company based in Aurora (United States) founded in 2020 by Ash Alizadeh, David Kurtz, Jake Chabon, and Maximilian Diehn was acquired by Natera in December 2025.. Foresight Diagnostics has raised $104.25 million across 3 funding rounds from investors including Natera, Pear VC and Foresite Capital. Foresight Diagnostics operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Aurora, United States
- Founders Ash Alizadeh, David Kurtz, Jake Chabon, Maximilian Diehn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Foresight Diagnostics
Foresight Diagnostics has successfully raised a total of $104.25M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $33 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $33.0M
-
First Round
First Round
(02 Jun 2021)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series B - Foresight Diagnostics | Valuation | Foresite Capital , Civilization Ventures |
|
| Apr, 2023 | Amount | Series B - Foresight Diagnostics | Valuation | Foresite Capital | |
| Jun, 2021 | Amount | Series A - Foresight Diagnostics | Valuation | Civilization Ventures , Bluebird Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Foresight Diagnostics
Foresight Diagnostics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Natera, Pear VC and Foresite Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Venture capital is provided to health tech and biology innovations.
|
Founded Year | Domain | Location | |
|
Bluebird Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Foresight Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Foresight Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Foresight Diagnostics Comparisons
Competitors of Foresight Diagnostics
Foresight Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Foresight Diagnostics
Frequently Asked Questions about Foresight Diagnostics
When was Foresight Diagnostics founded?
Foresight Diagnostics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Foresight Diagnostics located?
Foresight Diagnostics is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
Who is the current CEO of Foresight Diagnostics?
Jake Chabon is the current CEO of Foresight Diagnostics. They have also founded this company.
Is Foresight Diagnostics a funded company?
Foresight Diagnostics is a funded company, having raised a total of $104.25M across 3 funding rounds to date. The company's 1st funding round was a Series A of $12.5M, raised on Jun 02, 2021.
What does Foresight Diagnostics do?
Foresight Diagnostics was founded in 2020 and is based in Aurora, United States. A liquid biopsy testing platform is developed using PhasED-Seq technology to detect ctDNA levels in patients with solid tumors and hematologic malignancies. Operations focus on minimally invasive diagnostics within the biotechnology sector, enabling early cancer detection through non-invasive methods. The platform supports clinical applications for tumor monitoring and treatment response assessment.
Who are the top competitors of Foresight Diagnostics?
Foresight Diagnostics's top competitors include Guardant Health, GRAIL and Foundation Medicine.
Who are Foresight Diagnostics's investors?
Foresight Diagnostics has 8 investors. Key investors include Natera, Pear VC, Foresite Capital, Civilization Ventures, and Bluebird Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.